GEAR: Integrating a multimodal approach to address current challenges in immunotherapy (INTEGRAL)

Lahoutte, Tony (Administrative Promotor)
Devoogdt, Nick (Co-Promotor)
Keyaerts, Marleen (Co-Promotor)
Van Ginderachter, Jo (Co-Promotor)
Laoui, Damya (Co-Promotor)
Raes, Geert (Co-Promotor)
Breckpot, Karine (Co-Promotor)
Goyvaerts, Cleo (Co-Promotor)
Raes, Geert (Mandate)
Bridoux, Jessica (Mandate)
Baudhuin, Henri Vincent (Mandate)

18 Patent
3 Article

3 results

Filter

2024

Development and evaluation of a single domain antibody targeting folate receptor alpha for radioligand therapy
Dewulf, J., Massa, S., Navarro, L., Dekempeneer, Y., Santens, F., Ceuppens, H., Breckpot, K., Van Ginderachter, J. A., Lahoutte, T., D'Huyvetter, M. & Devoogdt, N., 19 Dec 2024, In: Journal of Nanobiotechnology. 22, 1, 13 p., 763.
Research output: Contribution to journal › Article › peer-review

Open Access

1 Citation (Scopus)
Preclinical evaluation of antigen-sensitive B7-H3-targeting nanobody-based CAR-T cells in glioblastoma cautions for on-target, off-tumor toxicity
Meeus, F., Funeh, C. N., Awad, R. M., Zeven, K., Autaers, D., De Becker, A., Van Riet, I., Goyvaerts, C., Tuyaerts, S., Neyns, B., Devoogdt, N., De Vlaeminck, Y. & Breckpot, K., 19 Nov 2024, In: Journal for ImmunoTherapy of Cancer. 12, 11, 16 p., e009110.
Research output: Contribution to journal › Article › peer-review

Open Access
File

1 Citation (Scopus)

9 Downloads (Pure)
2023
Size-advantage of monovalent nanobodies against the macrophage mannose receptor for deep tumor penetration and tumor-associated macrophage targeting
Erreni, M., D'Autilia, F., Avigni, R., Bolli, E., Arnouk, S. M., Movahedi, K., Debie, P., Anselmo, A., Parente, R., Vincke, C., van Leeuwen, F. W. B., Allavena, P., Garlanda, C., Mantovani, A., Doni, A., Hernot, S. & Van Ginderachter, J. A., 1 Jan 2023, In: Theranostics. 13, 1, p. 355-373 19 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
14 Citations (Scopus)

31 Downloads (Pure)